Disney's streaming business – fueled by the phenomenal box office results of “Avengers” – is on track to dramatically transform Disney's long-term growth. Read More...
Business
Investor’s Business Daily
These 2 Drug Giants Beat Earnings Views; But Only One Entered Buy Range
Teva Earnings Beat, But Sales Short For its first quarter ended March 31, Teva earnings were 60 cents per share, excluding some items, on $4.3 billion in sales. On a year-over-year basis, Teva earnings slipped 36.2% and sales fell 15%, or 12% in constant currency. Teva earnings beat the average estimate of analysts polled by Zacks Investment Research for 58 cents per share.
Add Comment